NOVOZYMES A/S - CVR: 10007127

2020,

29.04.2021

Bruttoresultat

Na.

Primær drift

Na.

Årets resultat

Na.

Aktiver

Na.

Kortfristede aktiver

Na.

Egenkapital

Na.

Afkastningsgrad

0 %

Soliditetsgrad

0 %

Likviditetsgrad

0 %

Resultat

29.04.2021

Årsrapport	29.04.2021	2017 21.03.2018	2016 01.03.2017	2015 04.03.2016
Nettoomsætning					14.531.000.000	14.142.000.000	14.002.000.000
Resultat af primær drift	0	4.047.000.000	3.946.000.000	3.884.000.000
Indtægter af kapitalandele (tilknyttede og associerede)	0
Finansielle indtægter	0	90.000.000	32.000.000	4.000.000
Finansieringsomkostninger	0	-247.000.000	-66.000.000	-261.000.000
Andre finansielle omkostninger	0
Resultat før skat	0	3.876.000.000	3.881.000.000	3.621.000.000
Resultat	0	3.120.000.000	3.050.000.000	2.825.000.000
Forslag til udbytte	0

Aktiver

29.04.2021

Årsrapport	2017 21.03.2018	2016 01.03.2017	2015 04.03.2016
Kortfristede varebeholdninger	2.586.000.000	2.488.000.000	2.281.000.000
Kortfristede tilgodehavender fra salg og tjenesteydelser	2.554.000.000	2.680.000.000	2.558.000.000
Likvider	363.000.000	805.000.000	796.000.000
Kortfristede aktiver	6.137.000.000	6.393.000.000	6.148.000.000
Immaterielle aktiver og goodwill	2.432.000.000	2.737.000.000	2.676.000.000
Finansielle anlægsaktiver
Materielle aktiver	0	0	0
Langfristede aktiver	12.236.000.000	12.266.000.000	11.643.000.000
Aktiver	18.373.000.000	18.659.000.000	17.791.000.000

Aktiver

29.04.2021

Passiver

29.04.2021

Årsrapport	29.04.2021	2017 21.03.2018	2016 01.03.2017	2015 04.03.2016
Forslag til udbytte	0
Egenkapital	0	11.267.000.000	11.745.000.000	11.593.000.000
Hensatte forpligtelser	0
Langfristet gæld til banker	0
Anden langfristet gæld	0
Langfristede forpligtelser		2.529.000.000	3.352.000.000	2.898.000.000
Kortfristede forpligtelser		4.577.000.000	3.562.000.000	3.300.000.000
Leverandører af varer og tjenesteydelser	0
Kortfristede forpligtelser	0
Gældsforpligtelser	0
Forpligtelser	0	7.106.000.000	6.914.000.000	6.198.000.000
Passiver	0	18.373.000.000	18.659.000.000	17.791.000.000

Passiver

29.04.2021

Nøgletal

29.04.2021

Årsrapport	29.04.2021	2017 21.03.2018	2016 01.03.2017	2015 04.03.2016
Afkastningsgrad	Na.	22,0 %	21,1 %	21,8 %
Dækningsgrad
Resultatgrad	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.
Egenkapitals-forretning	Na.	27,7 %	26,0 %	24,4 %
Payout-ratio	Na.
Gældsdæknings-nøgletal	Na.	1.638,5 %	5.978,8 %	1.488,1 %
Soliditestgrad	Na.	61,3 %	62,9 %	65,2 %
Likviditetsgrad	Na.

Resultat

29.04.2021

Gæld

29.04.2021

Årsrapport

29.04.2021

Nyeste:01.01.2020- 31.12.2020(offentliggjort: 29.04.2021)

Beretning

29.04.2021

Ledelsespåtegning:The Board of Directors and the Executive Management have today considered and approved the Annual Report of Novozymes A/S for the nancial year January 1 – December 31, 2020. The Consolidated Financial Statements have been prepared in accordance with International Financial Reporting Standards as adopted by the EU and further requirements in the Danish Financial Statements Act, and the Parent Company Financial Statements have been prepared in accordance with the Danish Financial Statements Act. Management’s Review has been prepared in accordance with the Danish Financial Statements Act. In our opinion, the accounting policies used are appropriate, and the Group’s internal controls relevant to preparation and presentation of the Annual Report are adequate. The Consolidated Financial Statements and the Parent Company Financial Statements give a true and fair view of the nancial position at December 31, 2020 of the Group and the Parent Company andof the results of the Group and the Parent Company operations and consolidated cash ows for the nancial year January 1 – December 31, 2020. In our opinion, Management’s Review includes a true and fair account of the development in the operations and nancial circumstances of the Group and the Parent Company, of the results for the year, and of the nancial position of the Group and the Parent Company as well as a description of the most signicant risks and elements of uncertainty facing the Group and the Parent Company. Novozymes’ Consolidated environmental data and the Consolidated social and governance data and the related notes, have been prepared in accordance with the reporting principles of materiality, inclusivity, responsiveness and the accounting policies. In our opinion, they give a true and fair view of the organisation’s environmental, social and governance performance in accordance with these principles. In our opinion, the Annual Report of Novozymes A/S for the nancial year January 1 - December 31, 2020 identied as NOVOZYMES-2020-12-31. zip is prepared in all material respects, in compliance with the ESEF Regulation. We recommend that the Annual Report beadopted at the Annual Shareholders’ Meeting.